IGEA Pharma NV
F:3B5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IGEA Pharma NV
F:3B5
|
NL |
|
P
|
Pennant Group Inc
NASDAQ:PNTG
|
US |
|
Musti Group Oyj
F:49U
|
FI |
|
Shakti Pumps India Ltd
NSE:SHAKTIPUMP
|
IN |
|
Meghmani Organics Ltd
NSE:MOL
|
IN |
|
T
|
Tekna Holding ASA
OSE:TEKNA
|
NO |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 3B5.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
3B5 Competitors Multiples
IGEA Pharma NV Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NL |
|
IGEA Pharma NV
F:3B5
|
505.5k EUR | 0 | 0.4 | -3 | -3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
174.2B USD | 3.9 | 26.8 | 15.4 | 21.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160B USD | 16.2 | 57.1 | 43.2 | 53.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129.7B USD | 5.3 | 40.9 | 20.8 | 25.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.9B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.6B USD | 4.7 | 32.3 | 19.2 | 25.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.6B EUR | 1.8 | 20.2 | 11.3 | 15.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.5 | 42.3 | 23.1 | 25.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.9B USD | 10.6 | 43.2 | 30.6 | 33.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.6B USD | 1.6 | 16.1 | 11.6 | 14 |